A shadow market for unlicensed weight-loss drugs is propelled by social media fitness personalities and vendors on messaging platforms, based on recent findings.
Investigational Drug Gaining Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by online personalities for its supposed fat-burning properties. Viewers are urged to contact these accounts privately for source information, while also obtaining promotional offers.
Active Commerce on Messaging Platforms
Separately, a robust trade exists on messaging services, where communities with thousands of members share comparison images, injection guides and claims of rapid British shipping. Vendors market the drug there before redirecting buyers to WhatsApp for purchases.
Understanding The Experimental Drug
Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials suggest it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the next Ozempic.
Medical Professionals Express Worries
However, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the United Kingdom is worrisome and could result in individuals administering substances of unknown origin.
Several experts stated the demand for retatrutide could be connected to the increasing price of approved slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for human use under the British medical regulations.
Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach pharmaceutical, marketing, and consumer regulations, potentially leading to fines, prosecution or prison.
Platform Reaction and Content Removal
According to the social media company, the service has taken down violative material and banned associated hashtags and search suggestions. The company stated it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.
Digital Marketplace Operations
Research also found groups with up to nine thousand participants selling retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up channels with numerous of users, populated with photos of slimming results, glowing reviews and step-by-step instructions for preparing or injecting at home.
After minutes of entering one group, a vendor posted WhatsApp details, where most purchases occur. The seller sent an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. Not one asked about weight, health issues or past usage.
Item Details and Pricing
Inside these groups, messages show black plastic packages with postal service stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20mg. When asked how much time a pen should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Platform Moderation and Security Actions
A representative for the messaging service said it regularly monitored dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are injecting substances they can’t verify. Even if the research behind this drug is valid, these online versions may not include what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.
A medical professional of an online medical service linked the increase in demand to current cost increases for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are using social media. But fake injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she explained.
Her team has already seen individuals harmed by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These materials could be impure or improperly measured.”
Manufacturer Position
A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject users to potentially serious medical dangers”.
